famotidine has been researched along with alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kawabe, T; Kobayashi, K; Matsumoto, S; Morishima, T; Okamoto, T | 1 |
1 other study(ies) available for famotidine and alpha-Neup5Ac-(2->3)-beta-D-Galp-(1->4)-[alpha-L-Fucp-(1->3)]-D-GlcpNAc
| Article | Year |
|---|---|
Cimetidine inhibits cancer cell adhesion to endothelial cells and prevents metastasis by blocking E-selectin expression.
Topics: Animals; Cell Adhesion; Cell Nucleus; Cimetidine; Colorectal Neoplasms; Dose-Response Relationship, Drug; Down-Regulation; E-Selectin; Endothelium, Vascular; Enzyme Inhibitors; Enzyme-Linked Immunosorbent Assay; Famotidine; Histamine H2 Antagonists; Humans; Interleukin-1; Liver Neoplasms; Mice; Mice, Nude; Microscopy, Confocal; Neoplasm Transplantation; NF-kappa B; Oligosaccharides; Ranitidine; RNA, Messenger; Sialyl Lewis X Antigen; Transcriptional Activation; Tumor Cells, Cultured; Umbilical Veins | 2000 |